ography (CTA) as the diagnostic tool
of choice. Level of recommendation: Grade 1 (Strong),
Quality of Evidence: B (Moderate).
1.2: In patients who are thought to have RAA and have
increased radiation exposure risks or renal insufﬁciency,
we recommend non-contrast-enhanced magnetic resonance angiography (MRA) to establish the diagnosis.
Level of recommendation: Grade 1 (Strong), Quality of
Evidence: C (Low).

From the Division of Vascular Surgery, University of Pittsburgh Medical Center,

Landry, Mahmoud Malas, Katherine McGinigle, J. Sheppard Mondy, Marc

Pittsburgha; the Division of Vascular Surgery, Johns Hopkins Hospital, Baltimoreb; the Division of Vascular Surgery, University of Michigan Hospitals,
Ann Arborc; the Division of Vascular Surgery, University Hospitals Case Medi-

Schermerhorn, Cynthia Shortell.
Correspondence: Rabih A. Chaer, MD, University of Pittsburgh Medical Center,
200 Lothrop St, Pittsburgh, PA 15213 (e-mail: chaerra@upmc.edu).

cal Center, Clevelandd; the Division of Vascular Surgery, New York University

The editors and reviewers of this article have no relevant ﬁnancial relationships to

Langone Medicine Center, New Yorke; and the Mayo Clinic Evidence-Based

disclose per the JVS policy that requires reviewers to decline review of any

Practice Center, Rochester.f

manuscript for which they may have a conﬂict of interest.

Author conﬂict of interest: none.

0741-5214

Independent peer review and oversight have been provided by members of

Copyright Ó 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.

the Society for Vascular Surgery Document Oversight Committee: Drs

https://doi.org/10.1016/j.jvs.2020.01.039

Thomas L. Forbes (Chair), Ruth Bush (Vice-Chair), Neal Barshes, Keith Calligaro, Ronald L. Dalman, Mark Davies, Yazan Duwayri, Alik Farber, Gregory

3S

4S

Chaer et al

Journal of Vascular Surgery
July Supplement 2020

Technical remark: Non-contrast-enh